Christelle Boglione-Kerrien

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical virologyImmunogenetics (incl. genetic immunology)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2026
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.

|Jul 22, 2026
Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?

|Oct 05, 2023
Can we predict the influence of inflammation on voriconazole exposure? An overview.

Christelle Boglione-Kerrien, Selim Zerrouki, Audrey Le Bot

|Jan 26, 2023
Contribution of voriconazole N-oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection.

Christelle Boglione-Kerrien, Jeff Morcet, Lucie-Marie Scailteux

|Jun 02, 2021
Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?

Florian Reizine, Kieran Pinceaux, Mathieu Lederlin

|Sep 22, 2017
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies.

C Boglione-Kerrien, S Picard, C Tron

Pageof 1

Frequent Collaborators

2 joint publications

Elodie Gautier-Veyret

2 joint publications

Florian Lemaitre

2 joint publications

Jean-Pierre Gangneux

1 joint publications

Florian Reizine